Summary
The limited success of thrombolytic therapy and the high percentage of patients who have to be excluded from lysis has resulted in the alternative application of primary PTCA in acute myocardial infarction. Randomized studies so far available have shown a significant decrease of hospital mortality by primary PTCA as compared to thrombolysis. Adjuvant stent implantation and a wider administration of glycoprotein IIA/IIIB inhibitors may further reduce mortality. For logistic and financial reasons however, not all patients with acute myocardial infarction can benefit from this therapeutic approach in spite of the high density of health care in Germany. Primary PTCA in acute myocardial infarction should be left to experienced centres and investigators. Of utmost importance is a reduction of the present “onsetto-opening” times by information campaigns, an improved triage, use of transportation times for pre-hospital lysis and improved thrombolytic agents.
Zusammenfassung
Der limitierte Erfolg der Thrombolysetherapie und der hohe Prozentsatz von Patienten, die von einer Lysebehandlung aus- geschlossen werden müssen, hat zur alternativen Anwendung der primären PTCA bei akutem Myokardinfarkt geführt. Aus den bisher vorliegenden randomisierten Studien ergibt sich eine im Vergleich zur Thrombolyse signifikante Reduktion der Hospitalsterblichkeit durch primäre PTCA. Durch adjuvante Stent-Implantation und den breiteren Einsatz von Glycoprotein IIA/IIIB-Inhibitoren ist eine weitere Senkung der Sterblichkeit erreichbar. Eine flächendeckende Versorgung aller Patienten mit akutem Myokardinfarkt ist trotz der hohen Versorgungsdichte in der Bundesrepublik aus logistischen und finanziellen Gründen nicht zu verwirklichen. Die primäre PTCA beim akuten Myokardinfarkt sollte in den Händen erfahrener Zentren und Untersucher bleiben. Vordringlich ist eine Verkürzung der gegenwärtigen „onset-to-opening“-Zeiten durch Aufklärungskampagnen, eine bessere Triage, Nutzung der Transportzeiten für prästationäre Lyse und bessere Thrombolytika.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
DeWood M, Spores J, Notske R, Mouser L, Burroughs R, Golden M, Lang H (1980) Prevalence of total coronary occlusion during the early hours of transmural infarction. New Engl J Med 303: 897–902
Davies M, Thomas A (1985) Plaque fissuring — the cause of acute myocardial infarction, sudden ischemic death and crescendo angina. Br Heart J 53:363–373
Davies S, Marchant B, Lyons J, Timmis A, Rothman M, Layton C, Balcon R (1990) Coronary lesion morphology in acute myocardial infarction: demonstration of early remodeling after streptokinase treatment. J Am Coll Cardiol 16:1079–1086
Reimer K, Lowe J, Rasmussen M, Jennings R (1977) The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation 56:786–794
Gruppo Italiano per lo Studio della Streptochinase nell’Infarto Miocardico G (1986) Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet I:397–402
ISIS-2 Collaborative Group (1988) Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17.187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 11:349–360
ISIS-3 Collaborative Group (1992) A randomized comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarction. Lancet 339:753–770
The GUSTO Angiographie Investigators (1993) The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. New Engl J Med 329:1615–1622
The GUSTO Investigators (1993) An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. New Engl J Med 329:673–682
Anderson J, Karagounis L, Becker L, Sorensen S, Menlove R and for the TEAM-3 investigators (1993) TIMI perfusion grade 3 but not grade 2 results in improved outcome after thrombolysis for myocardial infarction. Ventriculographic, enzymatic and electrocardiographic evidence from the TEAM-3 study. Circulation 87:1829–1839
Braunwald E (1993) The open-artery theory is alive and well — again. New Engl J Med 329:1650–1652
Gersh B (1998) Current issues in reperfusion therapy. Am J Cardiol 82 (Suppl P):3P–11P
Meyer J, Merx W, Dorr R, Lamberzt H, Bethge C, Effert S (1982) Successful treatment of acute myocardial infarction shock by combined percutaneous transluminal coronary recanalization (PTCR) and percutaneous transluminal angioplasty (PTCA). Am Heart J 103:132–134
Hochmann J, Sleeper L, Webb J, Sanborn T, White H, Talley J et al and f.t. S investigators (1999) Early revascularisation in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med 341:625–634
Perez-Castellano N, Garcia E, Serrano J, Elizaga J, Soriano J, Abeytua M, Botas J, Rubio R, Lopez E de Sa, Lopez-Sendon J, Delcan J (1999) Efficacy of invasive strategy for the management of acute myocardial infarction complicated by cardiogenic shock. Am J Cardiol 83:989–993
Schwimmbeck P, Spencker S, Hohmann C, Horstkotte D, Behrens S, Pauschinger M, Morguet A, Piper C, Kuersten B, Schultheiss H (1999) Heparinized stents in acute myocardial infarction: first results from the BESSAMI (Berlin Stent Study in Acute Myocardial Infarction) trial. Europ Heart J 20 Abstr Suppl: 170
Stone G (1998) Stenting and IIb/IIa receptor blockade in acute myocardial infarction: an introduction to the CADILLAC trial. J Invas Cardiol 10 Suppl B:36B–47B
Flachskampf F, Ellis S (1998) Rescue percutaneous transluminal coronary angioplasty. Current Opinion in Cardiology 13:289–293
The GUSTO Angioplasty Substudy Investigators (1997) A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. New Engl J Med 336:1621–1628
Elizaga J, Garcia E, J Delcan, Garcia-Robles J, Bueno H, Soriano J, Abeytua M, Lopez-Bescos L (1993) Primary coronary angioplasty vs systemic thrombolysis in acute anterior myocardial infarction: in-hospital results from a prospective randomized trial. Circulation (Suppl I):I–411
Garcia, E, Elizaga J, Soriano AM, Botas J, Fernandez A, Rubio R, Lopez E, Lopez-Sendon J, Delcan J (1997) Primary angioplasty versus thrombolysis with tPA in anterior myocardial infarction: results from a single center trial. J Am Coll Cardiol 29:389A
Gibbons R, Holmes D, Reeder G, Bailey K, Hopfenspirger M, Gersh B (1993) Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. New Engl J Med 328:685–691
Grines C, Broune K, Marco J (1993) A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. New Engl J Med 328:673–679
Kedev S, Petrovski B, Kotevski V, Antov S, Sokolov I, Jovanova S (1997) Primary coronary angioplasty versus intravenous streptokinase in acute myocardial infarction. J Am Coll Cardiol 29:91A
Ribeiro E, Carneiro R, D’Oliveira L, Gasquez A, Amino J, Tavares J, Petrizzo A, Torossian S, Duprat-Filho R, Buffolo E, Ellis S (1993) Randomized trial of direct coronary angioplasty, versus intravenous streptokinase in acute myocardial infarction. J Am Coll Cardiol 22: 376–380
Ribichini F, Steffenino G, Dellavalle A, Ferrero V, Vado A, Feola M, Uslenghi E (1998) Comparison of thrombolytic therapy and primary coronary angioplasty with liberal stenting for inferior myocardial infarction with precordial ST-segment depression. Immediate and long-term results od a randomized study. J Am Coll Cardiol 32:1687–1694
Vermeer F, Werter C, vd Berg E, Boehmer T, Dassen W, Krijne R, v Ommen W, Ophuis T, Bär F (1997) Safety and feasability of recue PTCA or primary PTCA in patients with acute myocardial infarction admitted to a hospital without PTCA facilities. J Am Coll Cardiol 29:390A
Zijlstra F, de Boer M, Beukema W, Liem A, Reiffers S, Huysmanns J, Hoorntje J, Suryapranata H, Simoons M (1996) Mortality, reinfarction, left ventricular ejection fraction and costs following reperfusion therapies for acute myocardial infarction. Eur Heart J 17:382–387
Fleiss J (1993) The statistical basis of meta-analysis. Statist Meth Med Res 2:121–145
Zijlstra F, Beukema W, van’t Hof A, Liem A, Reiffers S, Hoorntje J, Suryapranata H, de Boer M (1997) Randomized comparison of primary coronary angioplasty with thrombolytic therapy in low risk patients with acute myocardial infarction. J Am Coll Cardiol 29:908–912
Gibson C, Cannon C, Greene R, Sequeira R, Margorien R, Leya F, Diver D, Bairn D, Braunwald E and for the TIMI 4 study group (1997) Rescue angioplasty in the Thrombolysis in Myocardial Infarction (TIMI) 4 trial. Am J cardiol 80:21–26
Miller J, Ohman E, Schildcrout J, Smalling R, Betriu A, Califf R, Topol E (1998) Survival benefit of abciximab administration during early rescue angioplasty: analysis of 387 patients from GUSTO-III trial. J Am Coll Cardiol 31:191A
Ellis S, da Silva E, Heyndrickx G, Talley D, Cernigliaro C, Steg G, Spaulding C, Nobuyoshi M, Erbel R, Vassanelli C, Topol E and for the RESCUE Investigators (1994) Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardlial infarction. Circulation 90:2280–2284
King S, Douglas J (1990) Coronary plaque morphology in postinfarction patients: implications for early versus deferred coronary angioplasty. J Am Coll Cardiol 16:1087–1088
Antoniucci A, Santoro G, Bolognese L, Valenti R, Trapani M, Fazzani P (1998) A Clinical trial comparing primary stentig of the infarct-related artery with optimal primary angioplasty for acute myocardial infarction. Results from the Florence randomized elective stenting in acute coronary occlusions (FRESCO) trial. J Am Coll Cardiol 31:1234–1239
Hoorntje J, Suryapranata J, deBoer J, Zijlstra F, van’t Hof A, vandenBrink L (1996) ESCOBAR: Primary stenting for acute myocardial infarction: preliminary results of a randomized trial. Circulation 94 (Suppl):I–570
Horstkotte D, Piper C, Andresen D, Linderer T, Schwimmbeck P, Oeff M, Schultheiss H (1996) Stent implantation in acute myocardial infarction: results of a pilot study with 80 consecutive patients. Eur Heart J 17 Abstr Suppl, 297
Katz S, Chepurko L, Ong L, Green S, Rosenband M (1996) Is stent deployment during acute myocardial infarction superior to balloon angioplasty? Circulation 94 (Suppl I):I–576
Rodriguez A, Bernardi V, Fernandez M, Mauvecin C, Ayala F, Santaera O, Palacios I, Ambrose J and on behalf of the GRAMI investigators (1998) In-hospital and late results of coronary stents versus conventional balloon angioplasty in acute myocardial infarction (GRAMI trial). Am J Cardiol 81:1286–1291
Saito S, Hosokawa G, Kim K, Tanaka S, Miyake S (1996) Primary stent implantation without coumadin in acute myocardial infarction. J Am Coll Cardiol 28:74–81
Saito S, Hosokawa G, Suzuki S, Nakamura S and for the Japanese PASTA trial study group (1997) Primary stent implantation is superior to balloon angioplasty in acute myocardial infarction. The result of Japanese PASTA (Primary angioplasty vesusstent implantation in acute myocardial infarction) trial. J Am Coll Cardiol 29:390A
Stone G, Brodie B, Griffin J, Morice M, Costantini C, Goar FSt, Overlie P, O’Neill W, Grines C and for the PAMI stent pilot trial investigators (1998) Prospective, multicenter study of the safety and feasbility of primary stenting in acute myocardial infarction: in-hospital and 30-day results of the PAMI Stent Pilot trial. J Am Coll Cardiol 31:23–30
Suryapranata H, van’T Hof A, Hoorntje J, deBoer M, Zijlstra F (1998) Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction. Circulation 97:2502–2505
Wright R, Nunez B, Reeder G, Kopecky S, Garrat K (1997) Intracoronary stent therapy enhances luminal diameter and reduces residual stenosis in a subset of patients with acute myocardail infarction. J Am Coll Cardiol 29:236A
Giri S, Mitchel J, Kiernan F, Hirst J, Khan M, Mennet R, Waters D, McKay R (1998) Angiographic complications of primary coronary angioplasty in patients being treated for acute myocardial infarction. J Am Coll Cardiol 31:199A
Mercho N, Eldin A, Shareef B, Glazier J, Abbas S, Bauer H, Hirst J, Kiernan F (1996) Angiographic complications of primary angioplasty. Am Coll Cardiol 27 (Supplement A):61A
Grantham J, Hasdai D, Kopecky S, Holmes D (1998) Platelet glycoprotein IIb/IIIa receptor inhibition during PTCA for acute MI: a retrospective analysis of in hospital and one year outcome. J Am Coll Cardiol 31:231A
Lefkovits J, Ivanhoe R, Califf R, Bergelson B, Anderson K, Stoner G, Waisman H, Topol E (1996) Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (abciximab) on acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infarction. Am J Cardiol 77:1045–1051
Stone G, Marsalese D, Brodie B, Griffin J, Donohue B, Costantini C, Balestrini C, Wharton T, Esente P (1997) A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. J Am Coll Cardiol 29:1459–1467
van’t Hof A, Liem A, de Boer M, Hoorntje J, Suryapranata H, Zijlstra F (1999) A randomized comparison of intra-aortic balloon pumping after primary coronary angioplasty in high risk patients with acute myocardial infarction. Eur Heart J 20:659–665
Schreiber T, Kaplan B, Gregory M, Brown C, Rizik D, Masden R, Brahimi A, O’Neill W (1997) Transluminal extraction atherectomy vs. balloon angioplasty in acute ischemic syndromes (TOPIT): hospital outcome and six-month status. J Am Coll Cardiol 29:132A
Nakagawa Y, Matsuo S, Kimura T, Yokoi H, Tamura T, Hamasaki N, Nosaka H, Nobuyoshi M (1999) Thrombectomy with AngioJet catheter in native coronary arteries for patients with acute or recent myocardial infarction. Am J Cardiol 83:994–999
Nakagawa Y, Matsuo S, Tamura T, Yokoi H, Hamasaki N, Kimura T, Nosaka H, Nobuyoshi M (1998) AngioJet thrombectomy catheter for acute myocardial infarction. J Am Coll Cardiol 31:236A
Silva J, Ramee S, Kuntz R, Dandreo K, Popma J and for the VEGAS I and VEGAS II investigators (1998) Mechanical thrombectomy using the AngioJet catheter in the treatment of acute myocardial infarction. J Am Coll Cardiol 31:410A
Rosenschein U, Hertz I, Tenenbaum-Koren E, Thuesen L, Andersen H, Lanadio S, Miller H, Erbel R (1998) Coronary ultrasound thrombolysis in acute myocardial infarction: results from the ACUTE study. J Am Coll Cardiol 31:192A
Oesterle S, Bairn D, Hayase M, Ramee S, Teirstein P, Virmani R (1998) A coaxial catheter system for prevention of distal embolization. J Am Coll Cardiol 31:236A
Webb J, Carere R, Lo K, Ci L, McQueen C, Dodek A, Virmani R (1998) An emboli containment system for saphenous vein graft angioplasty. J Am Coll Cardiol 31:236A
Jhangiani A, Jorgensen M, Mansukhani P, Aharonian V, Mahrer P (1996) Communitiy practice of primary angioplasty for myocardial infarction. J Am Coll Cardiol 27 (Supplement A):61A
Caputo R, Ho K, Stoler R, Sukin C, Lopez J, Cohen D, Kuntz R, Berman A, Carrozza J, Bairn D (1997) Effect of continuous quality improvement analysis on the delivery of primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. Am J Cardiol 79:1159–1164
Caputo R, Lopez J, Stoler R, Sukin C, Ho K, Cohen D, Kuntz R, Berman A, Bairn D, Carrozza J (1996) The effect of institutional experience on the outcome of primary angioplasty for acute MI. J Am Coll Cardiol 27 (Supplement A): 62A
Christian T, O’Keefe J, DeWood M, Spain M, Grines C, Berger P, Gibbons R (1998) Intercenter variability in outcome for patients treated with direct angioplasty during acute myocardial infarction. Am Heart J 135:310–317
Ryan T, Anderson J, Antman E, Braniff B, Brooks N, Califf R, Hillis L, Hiratzka L, Rapaport E, Riegel B, Rössel R, Smith E, Weaver W (1996) ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary. Circulation 94: 2341–2350
Straumann E, Yoon S, Naegeli B, Frielingsdorf J, Gerber A, Schuiki E, Bertel O (1999) Hospital transfer for primary coronary angioplasty in high risk patients with acute myocardial infarction. Heart 82:415–419
Vermeer F, Oude-Ophuis A, vdBerg E, Brunninkhuis L, Werter C, Boehmer A, Lousberg A, Dassen W, Bär F (1999) Prospective randomised comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: a safety and feasability study. Heart 82: 426–431
Lincoff A, Topol E (1993) Illusion of reperfusion. Does anyone achieve optimal reperfusion during acute myocardial infarction? Circulation 88:1361–1374
Cannon C (1998) Time to treatment of acute myocardial infarction revisited. Current opinion in Cardiology 13:254–266
Zijlstra, F, de Boer M, Hoorntje J, Reiffers S, Reiber J, Suryapranata H (1993) A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. New Engl J Med 328:680–684
Zijlstra F, M de Boer, Ottervanger J, Hoorntje J, Suryapranata H (1993) Direct coronary angioplasty versus intravenous streptokinase in acute myocardial infarction: differences in clinical outcome during a mean follow-up of 18 months. Europ Heart J 14, Suppl. 279:279
Mannebach, H, Hamm C, Horstkotte D (2000) 15. Bericht über Struktur und Leistungszahlen der Herzkathterlabors in der Bundesrepublik Deutschland. Z Kardiol 89:55–61
Stone, G, Grines C, Browne K, Marco J, Rothbaum D, O’Keefe J, Harztier G, Overlie P, Donohue B, O’Neill W (1996) Influence of acute myocardial infarction location on in-hospital and late outcome after primary percutaneous transluminal coronary angioplasty versus tissue plasminogen activator therapy. Am J Cardiol 78
French W, Sada M and for the National Registry of Myocardial Infarction (NRMI-2) Investigators (1998) Benefit of primary angioplasty in patients presenting late with ST segment elevation and acute myocardial infarction. J Am Coll Cardiol 31:211A
Granger C, Califf R (1999) The GUSTO trials. J Interventional Cardiol 12:13–31
French W, Gore J (1993) Outcomes following primary coronary angioplasty for acute myocardial infarction in older patients. Circulation 88 (suppl I):I–411
Laster S, Rutherford B, Giorgi L, Shimshak T, McConahay D, Jonson W, Huber K, Ligon R, Hartzler G (1996) Results of direct percutaneous transluminal coronary angioplasty in octogenarians. Am J Cardiol 77:10–13
Stone, G, Grines C, Browne K, Rothbaum D, O’Keefe J, Harztier G, Overlie P, Donohue B, Chelliah N, Timmis G, Vliestra R, O’Neill W (1995) Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. J Am Coll Cardiol 25:370–377
Berger A, Schulman K, Gersh P, Breall J, Johnson A, Every N (1999) Primary coronary angioplasty vs thrombolysis for the management of acute myocardial infarction in elderly patients. JAMA 282:341–348
Gowda M, Vacek J, Hallas D (1998) One-year outcomes of diabetic versus nondiabetic patients with non-Q-wave acute myocardial infarction treated with percutaneous transluminal coronary angioplasty. Am J Cardiol 81:1067–1071
Karila-Cohen D, P Steg, Juliard J, Benamer H, Himbert D, Aumont M (1997) Impact of early reperfusion therapy on patency and survival in diabetic vs nondiabetic patients with acute myocardial infarction. J Am Coll Cardiol 29:367A
Amsterdam P, Tcheng J (1997) Platelet an thrombin inhibitors as adjuncts to thrombolytic therapy and percutaneous coronary interventions: a review. J Interv Cardiol 10:249–263
Willerson J, Zoldhelyi P (1999) Future directions in thrombolysis. Clin Cardiol 22 Suppl. IV:IV44–IV53
Gleichmann S, Miche E, Gleichman U, Poll M, Brunswig D (1994) Verkürzung der Prähospitalzeit in der Herzinfarkt Ostwestfalen-Lippe Studie (HOLS). Westf Ärzteblatt 3:15–17
Rustige J, Burczyk A, Senges J (1990) Akuter Herzinfarkt: Verkürzung der Prähospitalphase durch Massenaufklärung möglich. Dtsch Ärzteblatt 18:1056–1058
Rustige J, Senges J, Schöps W, Schiele R, Gillmann H (1991) Zu wenige Patienten mit akutem Herzinfarkt erhalten eine Thrombolyse. Dtsch Ärzteblatt 88: 2986–2988
Dracup K, Alonzo A, Atkins L, Bennet N, Braslow A, Clark L, Eisenberg M, Ferdinand K, Frye R, Green L, Hill M, Kennedy J, Kline-Rogers EMDK, Ornato J, Pitt B, Scot J (1997) The physicians role in minimizing prehospital delay in patients at high risk for acute myocardial infarction: recommendations from the National Heart Attack Alert Program. Ann Intern Med 126:645–651
Dracup K, Moser D (1991) Treatmentseeking behavior among those with signs and symptoms of acute myocardial infarction. Heart Lung 20:570–575
Mannebach H, Gleichmann U (1988) Akuter Myokardinfarkt. Früherkennung und prähospitale Phase. Kardio 6:40–44
Cannon C, Sayah A, Walls R (1999) Prehospital thrombolysis: an idea whose time has come. Clin Cardiol 22, Suppl. IV:IV10–IV19
Hunnius C (1993) Die Rinteln-Prähospital-Thrombolyse-Studie (RIPTS): intravenöse Thrombolysetherapie im Notarztwagen verglichen mit einer stationären Lyse beim akuten Myokardinfarkt in einem ländlichen Gebiet. Ruhr Universität, Bochum
Inderer T, Schröder R, Arntz R, Heineking M, Wunderlich W, Kohl K, Forycki F, Henzgen R, Wagner J (1993) Prehospital thrombolysis: beneficial effects of very early treatment on infarct size and left ventricular function. J Am Coll Cardiol 22: 1304–1310
Schofer J, Büttner J, Geng G, Gutschmidt K, Herden H, Mathey D, Moecke H, Polster P, Ruflopoulo A, Sheehan F, Voelz P (1990) Prehospital thrombolysis in acute myocardial infarction. Amer J Cardiol 66:1429–1433
The EMIP Group (1993) Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction. New Engl J Med 329:383–389
Weaver D, Cerqueira M, Halstrom A, Litwin P, Martin J, Kudenchuk P, Eisenberg M (1993) Prehospital-initiated versus hospital-initiated thrombolytic therapy. The myocardial infarction triage and intervention trial. JAMA 270:1211–1216
Assanelli D, Ferrari R, Bollani G, Bersatti F, Zywietz C (1998) Portable computerized diagnostic support for emergency cars. Regensburg
Canto J, Rogers W, Bowlby L, French W, Pearce D, Weaver W (1997) The prehospital electrocardiogram in acute myocardial infarction: is its full potential being realized? J Am Coll Cardiol 29: 498–505
Griebenow H (1998) Telematic based model of early diagnosis and treatment of acute coronary syndromes (ACS). Regensburg
Gibson C (1999) Primary angioplasty compared with thrombolysis: new issues in the era of glycoprotein IIb/IIIa inhibition and intracoronary stenting. Ann Intern Med 130:841–847
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Mannebach, H., Horstkotte, D. (2000). Akuter Myokardinfarkt: interventionelle Therapieoptionen. In: Arntz, HR., Schuster, HP. (eds) Die Notfalltherapie bei akutem Myokardinfarkt. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-642-57713-0_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-57713-0_10
Publisher Name: Steinkopff, Heidelberg
Print ISBN: 978-3-7985-1247-4
Online ISBN: 978-3-642-57713-0
eBook Packages: Springer Book Archive